Central Bank of Ireland speeches - "and there's more"...

Solvency II-ready?
"It's the way I tell them"...

I rejoiced on Friday at the sight of more speech material emerging from the Central Bank of Ireland directorate, if only due to the Frank Carson* gag I could wheel out due to the volume of their recent speech-giving...

As an industry we should always be happy to hear the regulator on lead vocals, so I gave the pair of speeches released a once-over to see what Irish concerns have justified the recent bounty of public addresses.

Deputy Governor Cyril Roux was very targeted in his speech, delivered to PwC's Annual CEO Dinner. It apparently gave him "great pleasure" to be in PwC's offices, which presumably means they weren't on the meter...

Some of the statistics and comments served to highlight that Ireland is something of a special case in the context of Solvency II, in that two-thirds of Irish gross premiums are to cover 'foreign risks', and that many insurers under their auspices will not have proximity to or oversight of much of their distribution network.

A few messages jumped out from the rest of the speech;

• A lot of positive messages had a caveat implicitly wrapped with them - "...we are in the main satisfied with your engagement with the Central Bank"; "On the whole international firms generally file returns on time..."; "I also commend your general adherence to our Corporate Governance Code..."
• Goes as far as using the IMF's recent review findings to tell firms to stop poaching regulatory staff while simultaneously complaining about turnaround time!
• Nice point about keeping focused on current risks through the PRISM framework, rather than drifting into Solvency II mode before 2016.
• Having recently been complimented by Sr. Bernadino on Ireland's reserving governance (p12), he reinforced that assumptions pertaining to reserves are expected to be "critically debated".
• On ORSA, that the CBoI "...expects to see Boards actively directing the use of risk management tools...such s stress or scenario testing"
• On Internal Modelling, he not only expects Boards to "...have sufficient knowledge and skill to challenge the model outputs", but adds that they "...like to see a Board direct the modellers in their firms to run specific stresses and scenarios prior to an item being discussed at the Board" - a big advance on previous murmurings on use test from supervisory bodies.
• Pulls up firms who are seemingly not tailoring their model's parameters for the Irish-specific business.
• Similarly a message of insisting that cross-border distributors tailor Group-driven materials and processes for the Irish market such as "...group policies and output, such as the ORSA, and internal model...".
• A cute but important distinction that "embedding" Solvency II, rather than complying with it on paper, is still going to take considerable effort.

Sylvia Cronin's speech (well, the Solvency II aspect of it) stayed along the same lines as she pursued at the Industry event in late April, where she was harsh on a number of specific elements in preparatory phase ORSA Reports which had been observed.

In a section of the speech covering "challenges to be overcome", a number of pieces of insistent ORSA direction are given, for example;

• "Your Board must use the ORSA to more fully align business strategy and capital"
• "You also need to use it as a lever to discharge your core responsibility not to take on risks and exposures which the capital base does not support".
•  "...there is a lot of work yet to do by firms to get this element of the new regime embedded to the extent we required" - I add here that, given they will have only reviewed 2014's preparatory phase ORSA Reports and Processes, is this not a given, particularly after CBoI sponsored a template-filling approach for the smaller firms?

On the wider world, the speech covers;

• That Solvency II sets out "clear standards and expectations around your internal control and risk management" - agree on the latter, but the former?
• Believes that the "scope for subjective judgement" may open up regulatory arbitrage opportunities, and that "a number of iterations" will be required before EU-wide consistency is achieved, in a sly dig at, errrr, everyone in mainland Europe! 
• Similarly, the volume of cross border business HQd in Dublin poses a problem due to the geographical boundary of CBoI's "prudential remit"
• Reinforces the message fro April that Pillar 3 readiness is a growing concern
• A large suite of views on Conduct Risk, where "culture" and "conduct" are hogtied together as the grimmest twins since DeVito and Schwarzenegger - that message won't be changing in a hurry, so I strongly recommend your work in that area caters to the supervisor's tastes.

Useful insight from what appears to be a supervisor with their sleeves rolled-up - keep up the good work.

* PS I know the connection is tenuous as he's a Belfast man, but give me a chance!

Solvency II Industry Forum in Ireland - Clint and Chocolate

Having treated the speech by EIOPA's Chair as the main course a few days ago, I'd better take a look at the hors d'ouevres and pudding. At the CBoI's industry event in late April, a couple of their biggest hitters delivered speeches of their own, with a similar tone to the PRA's effort in October (i.e. a considered yet firm rollicking).


Solvency II Marathon
- no Snickering...

Sylvia Cronin's speech, in which she referred to Solvency II as the "Marathon of Marathons", shone some light on how Ireland plc has dealt with ORSA during the preparatory phase. If you remember, the CBoI kindly provided ORSA templates for the entities lower down the PRISM spectrum, which I felt at the time was fully justifiable, and a tactic other NSAs should have adopted.

It wouldn't appear that the industry has performed exceptionally in their 2014 efforts, with Ms Cronin drawing attention to the following flaws in execution

• Variances in ORSA Report content between firms in similar sectors  "cause for concern" - a slightly worrying comment, given that some firms will be over-elaborating with content with the help of their friendly consultancy firm.
• Boards were aggressively called out on the "ownership" front. If your Boards have been ambivalent to-date with regards to participation in the ORSA process, they will seemingly get a hard time from now on.
• ORSA Process "...as important as the document itself" - music to my ears, and still a surprisingly difficult concept to convey
• The "so called use test" is referenced around ORSA, and not in the context of internal model applicants - no idea what that is about, so will assume it was a clumsy turn of phrase, rather than a new element of legislation
• Stress testing seen to be "too benign", with firms ignoring key risks and hard-to-quantify risks. Given that the UK firms received similar feedback on their 2014 ORSA stress testing efforts, it doesn't appear to be a country-specific failing.
• 'Local' (i.e. Irish) ORSAs which filter into wider Group ORSAs have not been adapted to fit the business model of the Irish entity. Good issue to pull firms up on, if they are relying Head Office to provide them with process and reports in template format 
• Business plan and forward looking time horizons not considered plausible, possibly a by-product of the lack of Board involvement in the ORSA Process

On the Pillar 3 front, she noted the following

• Pillar 3 is now a "cause for concern" - decisions by firms on architecture and expenditure "now overdue".
• Only half of High or Medium PRISM firms have participated in external user testing on Pillar 3. This still feels proportionally more than the PRA have tested out, though it is still viewed as a negative by the Bank.

"Problematic Applicant"?

Cyril Roux on the other hand wanted to reflect on "the good the bad and the ugly of Solvency II" in his address. While most executives paying for Solvency II programmes in EU insurance entities would suggest that "A Few Dollars More" is a more apt Clint Eastwood hook, he took a more macro view during which he;

• Patted the Irish regulator for its "good work" putting the house back in order after the laissez-faire approach at the start of this century. 
• Also reiterated that Pillar 3 preparations are light in the country, urging firms to "...devote the resources necessary"
• Dwelled heavily on the subjects of investment risk appetite and prudent person principle
• Pointed at "problematic applicants" who can now seek approvals to do business in the EU regardless of the supervisor's thoughts about their business models
• Called Solvency II's quantitative requirements "ill conceived" and "overboard" and "clearly too complex"
• Commented that SCR is "unlikely, unreliable tool to manage capital" - "...certainly the supervisor will not be using it for more than its worth".
• Gave short shrift to the abolition of prudential reserving under Solvency II, and indeed Bernadino referred glowingly to the Irish approach to reserving governance (presumably to counteract this grievance?) in his keynote speech.

A lot to be taken from these speeches if you have any dealings with Irish insurers, and with the clock ticking, I can't imagine there will be better steers than these during the preparatory phase.

Central Bank of Ireland and ORSA - fancy a bunch of FLAORs?

So the Central Bank of Ireland went and knocked together an ORSA Reporting tool for the less complex end of the Irish Insurance industry, specifically the "low" and "medium-low" rated insurers. And to think I have spent 4 years railing at the consultancy and supervisory industries for catering for the big boys, while ignoring the immaterial...


2014 FLAORs
- a serious affair

The tool was released back in July, and while it (intelligently?) copy-pastes EIOPA's guidance and dissects most of those words into a set of obvious questions, there are some aspects which are very revealing in respect of where supervisory expectations for 2014's ORSA reporting and process development efforts perhaps are at the less material end of the industry.

They have evidently taken the approach that most large programmes will have used over the last 3 years, namely to deconstruct paragraphs in Directive/Delegated Acts/EIOPA Guidelines in an Excel spreadsheet, and pose them as questions. Not every firm's budgets would have stretched to accommodate even that level of analysis though, so I'm sure the CBoI's efforts have been warmly received to date.

For example, the following elements are very shocking to me, given our proximity to go-live;

• No compulsion for ORSA Policy (and therefore process) to be documented and Board-approved in 2014 (2.3 and 2.4)
• No expectation that the 2014 version assesses one's ability to continue past the 1 year horizon (4.8)

These elements are perhaps revealing as to supervisory planning for 2015 and beyond;

• Asking when the Board approved the results and conclusions - likely to be hunting for evidence in minutes (2.2)
• Asking which personnel/units have been briefed as to the ORSA results - is there a feeling that outside of EXCOM and control functions, the reports won't see the light of day? (3.4)
• Highlight what they are really interested in, in the context of "overall solvency needs" quantification - risk measure, confidence level and time horizon, which feels proportionately light in focus given the detail in Article 262 of the Delegated Acts (4.1).

Some good elements include;

• Uses of ORSA in decision-making process listed in 1.1 - some are directly lifted from EIOPA, but couple of other examples may help focus the mind (I would add that setting "risk limits" feel sloppy, given the legislation uses "risk tolerance limits")
• Ask for a table to be populated with quantitative results for each risk category, but don't prescribe the category names, rather provide the legislative categories as examples - this is how it should be, especially for the smaller firms. (4.2)
• No expectation that the "medium or long-term" capital is calculated at this point - the column provided is marked *OPTIONAL* (4.2) 

Whilst the data gleaned from the template they have provided may be a bit cumbersome, fair to say that CBoI's efforts will be welcomed by both the qualifying firms (as a pro-forma) and the larger firms as an INED guide.

Central Bank of Ireland - Corporate Governance Code refresh

The Irish approach to corporate governance in financial services, at least up until the onset of the financial crisis in 2006/07, resembled something of an all-you-can-grasp buffet for a select number of executive golf club pals and octogenarian ex-politico Non-Executive Directors (NEDs), having their voting arms operated a la Weekend at Bernies.

Ireland pre-2007 - Waking NED?

The new FSA-flavoured approach brought in by Matthew Elderfield in 2009 (elaborated on here) fortified by the findings of a devastating 2011 report summarising the truly horrid governance practices in the Irish banking industry, has led to a change of regulatory tack at the Central Bank of Ireland that represents the biggest volte-face in Europe since the Macarena.

Alongside PRISM, a piece of revolutionary work in the assessment of financial institutions by supervisory bodies, the CBoI also made substantial changes in areas such as Annual Compliance Statements, Fitness and Probity of directors, Risk Appetite Statements.

All of this ran off the back of Mr Elderfield's first major gig in 2010, a full revamp of the Corporate Governance Code, which could hitch a ride off the back of the work of the FSA and CEIOPS (at the time!) and deliver a more substantial suite of obligations to a cabal of directors who, after feasting on carrots for years, desperately needed the stick.

This makes the release of yesterday's consultation on the Corporate Governance code a touch baffling, as the ink is barely dry on 2010's effort - it perhaps reflects that the regulator has reached optimum staffing levels if they can review it so regularly! Having said that, the level of divergence from accepted CG practices in the UK was flagged by Grant Thornton back in 2011 as being substantial, so a point-in-time revamp should not be so unwelcome, regardless of the proximity to the last one, and of course, all of this activity was too late to prevent Quinn Insurance from going down.

They emphasise that this review takes into account developments in the Solvency II space, as well as on-the-ground experience and publications from other parties of interest. Of particular note was their emphasis that, where national regulations are not as stringent as relevant EU or international one (or indeed vice versa?), the most onerous one should be complied with. In a number of instances around corporate governance, this will mean the CBoI outranking Solvency II as the more onerous of the two!

While these are proposals rather than stitched-on changes at this point, the CBoI doesn't have a great track record for backtracking these days. Highlights for me were;

Risk Committees

• Require a majority of NEDs on Risk Committees, and must be chaired by a NED

Committees in general

• Require the Risk Committee and Audit Committee chairs to sit on each other's committees
• Require the Remuneration Committee chair to sit on the Risk Committee
• In High Impact firms, the Risk Committee and Audit Committee Chair may not be the same person
• Must be at least 3 members of Risk Committees and Audit Committees

Chief Risk Officers

• They note that it is "Generally accepted best practice" to have a CRO who, amongst other tasks, is charged with "...facilitating risk appetite setting by the Board". In addition;
• All "High Impact" firms will be required to appoint a specialist CRO
• Firms with a lower PRISM rating may have a CRO who is shared with another control function, "...provided that there is no conflict of interest between the two roles". Can't help but feel that this might rule out CRO/Chief Actuary dual roles, but allows for CRO/Head of Compliance and CRO/Head of Internal Audit, which would be to the chagrin of the Society of Actuaries in Ireland!
• CRO to have direct access to the Chairman of the Board

Board Meeting frequency

• Seem to acknowledge that the compulsory 11 meetings per year for High Impact firms may be a touch much, so are looking for comments
• Also acknowledge that compulsory 1 meeting per calendar quarter is a bit constrictive for the smaller firms, so may relieve this to be pragmatic

Chairman and CEO

• Some of the restrictions around number of roles held at any one time to be relieved for smaller firms, but seemingly only to populate inter-Group roles.

Board Diversity

• Acknowledges that, while the debate in the EU is gender-centric, that diversity of all types is a worthy target for Boards, but falls short of compelling firms to do anything at national level, choosing to seek comments and wait for the supra-national activity to drive any compulsion. This seems to fit with the thinking of Irish directors published back in 2011 i.e. no "Golden Skirt" quotas.

Random

• "...appropriate Risk Culture" makes its way in (6.3), perhaps cognisant of the FSB's proposals
• Built in a piece which allows for video-conferencing rather than physical attendance at meetings (7.5)
• Board responsibilities updated (13.1)
• Compulsory Board skills matrix (14.9)

Risk Appetite white paper from Oliver Wyman - hold the onions...

A white paper on Risk Appetite from Oliver Wyman caught my eye recently whilst fishing for supporting materials for my own take on the matter. I have covered on this blog a range of opinion

Risk Appetite - need to 'ketchup' with
latest benchmarks?

pieces on Risk Appetite from the professional institutes to the consultancies to the regulators perspectives, and so far they never seem to be on the same page at the same time.

From the Solvency II perspective, we know that (as it stands) Risk Appetite only exists in written word in Level 3 System of Governance and ORSA guidance, namely;

• That the AMSB is "ultimately responsible" for setting it (Sys Gov G15)
• That EIOPA did not wish to distinguish between "risk appetite" and "risk tolerance", rather let national regulators and the industry scrap out any divergence in term usage themselves (Sys Gov p30-38!)
• On that basis, "Risk Appetite" doesn't even feature in the L3 ORSA Guidance, though "risk tolerance limits" do (ORSA G7 and G11), perhaps indicating what terminology EIOPA prefer.

From the national regulatory perspective, the PRA have ingrained its importance as the "foundation of [an insurer's] risk management framework" in its new approach paper (section 110), whilst the Central Bank of Ireland have not only built Risk Appetite into the supervisory structure, but even had time remonstrate with the industry for its lack of progress around Risk Appetite statements!

The ratings agencies expectations on Risk Appetite also come into play, with S&P expecting its "clear communication" and "linking to risk limits" as part of its ERM assessment programme (p5, and more extensively, p9). They do however have the courage to define their terms with respect to appetite, tolerance and preference in the appendix. 

Appreciating therefore the Oliver Wyman paper is catering outside of the financial services sector, it still contains a host of rather inane platitudes such as;

Risk Appetite Framework

"...bringing discipline to major strategy decisions" - as opposed to the Chief Exec and Chair? 

"...essential for firms considering an ambitious growth strategy" - as opposed to all firms?

"...developing a robust risk appetite framework does not take an inordinate amount of time and effort" - might want to tell that to the rest of the invoice-generating consultancy world!

Risk Appetite Statement

"...more than just a set of benchmarks" - at what point has a RAS ever been that?

"...setting the 'tone at the top' about the relationship between risk and return" - "tone" as opposed to "rules"? 

It also contains a number of apocryphal tales and irritants, such as

• Senior management "often" fail to take risk appetite into account - probably true even in the financial services world pre-2007 (indeed it was a major feature of the Lehman's autopsy!), but one would think less so now.
• "Few" companies able to unlock benefits of a risk appetite framework - that feels a bit light, though I don't doubt some firms may struggle depending on their corporate structure and industry.
• Frequently interchanging between "Framework" and "Statement" throughout, in the same way as many ORSA-related materials do so for "Process" and "Report".

It ultimately recommends that a Risk Appetite Framework should contain the following characteristics;

1. Qualitative and Quantitative Risk Appetite Statement
2. Ensure the statement content is "useful" for all internal stakeholders (Board, Senior Management, Financial analysis teams and business unit leaders"
3. Connect the statement to the planning, review and decision making processes and forums

There are also a number of positive elements within the document, which I would certainly advocate, such as;

• Size Limit - they recommend no more than 4 pages for a Risk Appetite Statement, and one could probably get away with less
• Concepts of Ability (what one can technically afford) and Willingness (to tolerate uncertainty)...
• ...applied as appropriate to a set of qualitative and quantitative themes which are pretty much ready off the shelf (p3)
• Ensuring the metrics used for monitoring are company-specific - very easy to replicate what one has seen in previous firms, but these will inevitably not make the cut in decision making processes, thus defeating the point.

I'll be doing more on this topic in the near future, but for now this material may at least be of use to you for benchmarking purposes.

Elderfield at the European Insurance Forum - one for the road...

So the European Insurance Forum is in full swing over in Dublin, which from what I have seen to date in the tweetosphere (thanks DIMA and Mike!), sounds more like Alan Partridge's sales conference for Ireland plc.

That aside, Matthew Elderfield, the outgoing Head of Financial Regulation at the Central Bank of Ireland, gave a rousing speech touching on risk-based supervision and the 'prospects' for Solvency II. As a member of EIOPA's management board and head of the second largest internal model assessment body in the EU, his words are very much worth heeding.

Given that he has already addressed this forum a couple of years ago on such matters, as well as being relatively outspoken  recently on the quality of components parts of Irish risk management systems, one might expect a few home truths on his way out of the door to an equally precarious task as Head of Compliance at Lloyds Banking Group.

EIF 2013 - More to Ireland 'dan dis'?

The headline acts for me was his revelation that diversification in internal models remains a bugbear, to the extent that he supports the kind of 'floor' arrangement being given airtime at the PRA. Given he had already made his distaste at the extent of the diversification benefits being sought clear in a speech last year, it is not surprise to see it on his agenda, more that it implies that the expert judgements of those involved in the calculation process may be overridden (due to regulatory prudence?), regardless of how well they are documented or supported. 

In addition, his angle on bridging the LTG issue makes interesting reading for anyone who doesn't receive briefings on EIOPA's inner workings.

Noteworthy points (my emphasis if emboldened) therefore included;

On Solvency II

• Drawn out process has "naturally resulted in a combination of fatigue and exasperation", with the "...high costs of preparation compounding concerns"
• Regardless, "it is unacceptable that the common regulatory framework for insurance in Europe in the 21st century is not risk-based"
• "Urgently need" the framework to reflect asset risks, riskiness of different lines of business, encourage better governance and risk management, and provide better disclosure.
• "Solvency II does indeed have its imperfections", but "...the benefits of moving ahead with Solvency II outweigh the costs..."
• Notes his "long-standing concern" around over-optimism in the calibration of internal models
• "...complexity has clearly gone too far in some areas - and makes implementation very difficult for smaller companies"

On Omnibus II and EIOPA's LTGA

• Omnibus II delay "...is a course of considerable concern to regulators and industry alike", and the "...entire framework is essentially stuck on one issue" which "...will require a political compromise"
• Personally supports a more generous approach to matched premium adjustments on certain lines of business, provided they are (a) only applied to the back-book, (b) companies provide Pillar 3 disclosures both with and without those adjustments, and (c) supervisors can apply capital charges if they are not happy.
• "With European elections looming next year, it is important that this process concludes in the autumn at the latest"

EIOPA - filling gaps
since 2013

On EIOPA's Interim Guidelines

• As justification for supporting them, "Much of the Solvency II framework is already clear", and emphasises that "we will adopt a proportionate approach"
• EIOPA is "helping 'fill the gap' created by the hiatus in the political negotiation"
• "The EIOPA initiative should be strongly welcomed by regulators and industry alike"
• Hopes the system of governance and ORSA interim guidance provide "manageable and useful transitional steps towards full Solvency II adoption"
• For Pillar 3, expecting "best efforts" especially from High Impact insurers, with the use of statutory powers held in reserve "as a last resort.
• For IMAP, can neither sanction an "early conclusion" nor a "hard stop", so will ultimately elongate the administrative burden, hopefully leaving less to do towards the end.

On Diversification benefits

• "...in common with a number of other [unnamed] supervisors", CBoI is concerned to ensure "prudent recognition of diversification effects"
• "Fundamentally, what is needed is a broad agreement on the outer bounds of acceptable levels of diversification in the model approval process", citing one jurisdiction (UK?) looking at hard SCR floors based on proportion of MCR.
• "...the Central Bank's message to Irish firms is to take a conservative approach to the recognition of diversification..."
• Points to the failure to add formal constraints on diversification benefits in the Directive text
• "Supervisory quants are at risk of being outgunned by industry quants in the minutiae of a correlation debate"
• Also has a stab at "overly generous approval" in other member states in the context of regulatory arbitrage - is it that hard to say "no" just because the home regulator says "yes"?

Of less consequence for those outside of Ireland, he goes on to cover the CBoI's bespoke work around VA-specific risks (in light of prolonged low interest rate environment), the failure of Quinn Insurance, and the bedding in of their PRISM risk-based supervisory framework, the latter eliciting the comment that "we are still some way from fully embedding our new approach".

From this, one might reasonably think that, should Mr Elderfield's successor continue in the same vein, that the correlation matrices of Ireland's 30-something IMAP candidates are likely to get a severe working over in the next couple of years. Let's hope the industry gets their documentation in order!

Elderfield speech to Institute of Directors in Ireland - 'the Gene Genie'

With all the subtlety of an American industrialist in Paris, Mr. Elderfield delivered a speech to the Irish IoD this week focused on the Central Bank of Ireland's refresh of its 3-year strategic plan, as well as reinforcing what it expects financial services Boards to be focusing on in the near future.

This of course should sit in the context of what I covered last week on thematic enforcement work in 2013. Aside from his comments around board diversity, namely that the CBoI's 'fit and proper' activity to date is "...broadening the gene pool of corporate life" (eeeewwwww!), emphasis was given  to three particular areas:

Risk Appetite Statements

• CBoI expects "... [a] high quality risk appetite statement that is well understood and implemented throughout the firm in practice"
• "...clear articulation of the acceptable level of risk...at different confidence levels, is an important discipline and an essential compliment to a well-articulated business strategy"
• That, due to disappointments in the past, Risk Appetite statements are "...certainly an area of increasing interest on [the regulator's] part, and where we are debating the best approach for encouraging improvements"

System of Governance and Risk Culture

• Boards should "...provide broad, challenging scrutiny of your firm's culture regarding regulatory compliance and internal challenge"
• Ensure that there are "...appropriately resourced and well-qualified risk management and compliance functions"
• "Think more fundamentally and strategically about the culture in the institution that you oversee"

I would add that a lot of this sits nicely with the FSB's Risk Governance paper which was released last week.

Board composition

• Expect directors to take a "...hard nosed view on Board composition, with a view to improving performance"
• Endeavour to attain the "...right gender diversity...and international experience"

With Risk Appetite and Risk Culture both having featured on the IRM's hitlist recently, the practitioners over there will have some assistance to hand from an industry body, however there should be some other useful stuff available in the tag cloud at the bottom of this page on appetite, culture and diversity if you are struggling for inspiration.

Central Bank of Ireland - Prudential regulatory agenda for 2013

A pretty meaty speech was delivered last week by the CBoI's head of life insurance supervision, covering the prudential regulatory agenda in Ireland for 2013 and beyond. In essence it is a rather sobering take on the flipside of the Celtic Tiger's death and its impact on what was an effervescent, if still fledgling, cross-border insurance industry, noting that new business volumes recorded in Ireland have declined for the 5th year in a row, and currently aggregate out at a break-even APE/PVNBP margin.

I found there was actually a lot to take from this on the ORSA front, and would recommend any readers on the Emerald Isle pick the bones out of it, in particular that the regulator "expects to see";

• Strategies reflecting "current market realities" - highlighting excessive commission to brokers, swollen lapse/surrender rates and reduced margins from over-competition.
• Tight management of costs
• Increased efforts put in place to retain existing in-force business
• "Credible business plans"
• Viable alternatives to grow business through distribution or product range changes (online facilities highlighted specifically)

While much of this may read as common sense, one can reasonably assume that the CBoI is not seeing enough evidence of this in the Financial Condition Reports and strategic plans that currently cross their desks, and are expecting a much meatier ORSA-type approach to managing strategic risks over the business planning period in the immediate future.

Solvency II compliance ahead of "Go-Live" date - over to you, regulators

Judging by the rather resigned tones around the achievability of Solvency II "go-live" by 2014 (CBoI recently joining the FSA) and 2015 (here and here), there appears to be a growing swell of support for implementing some of the less wobbly bits sooner rather than later.

While it's unlikely that there will be more spurious adoptions than a Madonna safari trip, it is interesting to see what we can point at to-date;

UK - ICA+ regime, which lends itself, subject to the quality of the ICA-to-SCR reconciliation, to implementation from as early as year-end 2013, though one suspects 2014 is a safer bet.

Germany - Cheeky bit of Pillar II, judging by Bafin's (indirectly quoted) comments on Reuters today, although what "some risk controls" actually means is another thing!

Ireland - via the sterling work on PRISM, fitness and probity and corporate governance, it's hard to argue where they are not already Pillar II Solvency II-equivalent (at least in word, if not in deed!)

France - reference to compulsory submissions to the ACP in XBRL by Q1 2014 at the bottom of this doc, apparently confirmed at a recent soiree.

So we could very well have 3 Pillar coverage by 2014, just randomly spread out over multiple countries...

Any more for any more?

Society of Actuaries in Ireland Newsletter - ORSA, Solvency II and Cocktails

Always a riveting read, the Irish Society of Actuaries fired out their newsletter for August, which as ever is a treasure trove for any diet-mathematicians like me who need to have things spelled out for them on all matters actuarial.

Of particular note was their report from the ORSA Working Party (p7), which covers a presentation and paper delivered earlier in the year - to show what a fantastic bunch the SAI are, you can access both the full working party paper (all 52 pages of it) and the presentation slides on their website. I picked out the following from the newsletter (I'll read the working party paper in more detail separately);

• "Compilation of the ORSA Document is quite a significant undertaking" - emphasising the difficulty in selling ORSA in purely process terms
• "ORSA is a risk management exercise, not a compliance exercise" - I would prefer to sell it as both, as it is unfair to undersell the compliance angle, particularly to smaller firms who may not have gone to the nth degree on projecting capital adequacy before.
• "ORSA needs to be readable..." - again, almost impossible not to talk about it as a report, rather than the report being the output of a process
• "ORSA would be of great interest to the Board" - I would hope that the Board would be queueing up next to the printer to get their hands on ORSA reporting output!
• Projecting the business planning period "...likely to be 3-5 years into the future" - interesting to see what the general consensus is on this (I feel this will fit most insurers, but if you are shooting for longer, would love to hear how you're doing it!)
• Some discussion over how prescriptive the Central Bank of Ireland may be on the ORSA documentation front (bearing in mind how liberal the FSA have been on this matter) - seems to suggest that a similar approach will be taken i.e. justify what you have.

There are a couple of nice pieces towards the back on unintended consequences of Solvency II and Basel III (on cost of capital and funding patterns), as well as some nice real world examples of why one should be wary of actuaries who manage to change internal model parameters in a way that magically reduces capital requirements each year!

The less said about the actuarial cocktail making class on the back page (complete with bottle of Kia-ora in centre shot) the better I suspect...

Elderfield speech to Insurance Day summit in Bermuda - equivalence, model approval and "hub and spoke"

Very informative speech delivered this week by Mr Elderfield from the Central Bank of Ireland to the Insurance Day summit held in his previous stomping ground of Bermuda (certainly a more welcoming climate that last month's summit in not-so-sunny London!).

He mainly covers equivalence, internal model applications and, as one might expect from the Emerald Isle, the potential for Hub and Spoke operations and the potential capital benefits of this technique (which has a sniff of Group Support about it in all but name). I noted the following;

General

• Suggests Solvency II provides "...an incentive for investment in risk management, including the use of internal models" - I would substitute "incentive" for "compulsion"!
• Singles out "small firms" as those which will "certainly" struggle to assimilate and implement Solvency II in its current guise
• Notes that "...the current target is that member state governments will domestically implement [Solvency II] by 30th June 2013" - I have emphasised the "current target", as the very wording suggests that there is an implication it is not the "final target"!

Model applications

• "...it is important that approval process doesn't get bogged down in detail such as endless documentation reviews" - cue some raised handbags down at Canary Wharf I suspect!
• Highlights expert judgements around correlation and diversification (as he has done this time last year) as being much more significant around challenging the solvency requirements calculated by the models, in particular the "swing" these elements have on the final numbers. On that premise, he puts these "...at the forefront of the regulatory approval process", as well as expecting them to generate the most challenge in the boardroom.
• Elaborates on the extent of Board challenge by commenting that "...boards should be expected to challenge vigorously the amount of diversification benefit being claimed in internal models, even if they don't know the internal plumbing of copulas or correlation matrices". Very telling comment, and clearly one to heed, bearing in mind he is on EIOPA's management board.

Hub and Spoke

• Seeing "considerable interest" in using Ireland for the "hub" of the "hub and spoke" business model - one may have said this was for regulatory arbitrage purposes 5 years ago, but I'm guessing corporation tax, falling wages and underemployment may have kept it in play even after the recent beefing up of the CBoI
• Comments that "...it will be interesting to see whether [the hub and spoke] model will grow as Solvency II gets closer to implementation - implies that not only does he think the existing corporate structures are not settled yet, but that Ireland is actively open for business in this regard.

Equivalence

• Not sure if he was just being polite to his hosts, but he commented "...Bermuda is very well placed for [the equivalence] assessment process" - again worth heeding in the context of his position at EIOPA, as well as Bermuda coming off worst of the 3 countries which have been assessed in wave 1.
• Suggests there should be some sort of early adopter's premium for Bermuda which makes it worth being ahead of those countries who may come in in wave 2 (no mention of one of their competitors Guernsey in this context, who continue to bang the IAIS ICP drum while stating categorically that they will not seek equivalence).

Good intelligence all in all - PS must try and swing an invite to one of these things when they go tropical!

Central Bank of Ireland - Solvency Matters newsletter, ORSA and models

The Central Bank of Ireland have released their latest Solvency II briefing letter (thanks to Mike Claffey for tweeting it).

Important to note the following from a UK and Ireland practitioner's perspective, on the premise that the two regulatory bodies in the UK and Ireland are setting the benchmarks in many respects;

• 'No panic' message given regarding the Omnibus II 'delays' - timetable unchanged in this regard
• No references to the Commission's draft Level 2 text as a basis for undertakings to use for internal model application activity (which the FSA went out of their way to advocate at their February IMAP event). Is there a legitimate reason for this, bearing in mind how useful the document is for applicants in ensuring their documentation addresses the final requirements, even if only 'there or there abouts'?
• Model applicants should be "well advanced with the technical aspects of their model build" - this is somewhat to the FSA's take, which was that build should be pretty much complete by now (p10)
• Some nice visceral examples of Use Test evidence requirements from undertakings, particularly around evidencing Board 'understanding' of the model - I would add that these seem onerous for NEDs, but reasonable for executives, so I would be interested to see how this is applied (could you for example see your non-industry, non-executive director justifying diversification benefits to your friendly local regulator? Is that a reasonable use of project resource/Board training time?)
• Board members will be interviewed by the CBoI individually "without the support of their technical experts" - I'll get my coat then...
• On ORSA, they "recognise that individual undertakings would like to get more details on specifics of the ORSA Reporting Process", but want undertakings to focus on the contributing processes themselves - easier said than done, particularly when even EIOPA had to relent from the mantra of 'ORSA is process, not a report' when they got to public consultation stage!

I'm sure that the industry will appreciate some of the clarity in here - they may appreciate the Commission's Level 2 draft a bit more though!

Risk Appetite Statements - Central Bank of Ireland not impressed

Good spot from Mike Claffey, flagging an finance industry-wide rollicking from the Central Bank of Ireland on the quality of Risk Appetite Statements, now of course a regulatory requirement.

Some extraordinary findings appear to have emerged, judging by the recommendations, for example;

• Board not signing off the appetite statement (never mind just signing off, how about formulating!)
• Non-coverage of material risks
• Statement not being communicated to relevant staff

With the advent of PRISM in 2012, there is clearly a desire to get ducks in a line on the Emerald Isle, and of course there is plenty of Risk Appetite guidance out there (some from Mr. Claffey himself at Milliman here, the IRM's take here, the Society of Actuaries in Ireland had a good stab here, but strangely nothing extensive on the FAQ front from the CBoI). Fair to say that excuses should be hard to come by then?

However, as I have mentioned earlier, having some paper perfect statements doesn't necessarily deliver the right outcome, as UBS will attest to!

PRISM and Central Bank of Ireland - ORSA come early?

Towards the end of last week, Matthew Elderfield launched the Probability Risk and Impact SysteM (PRISM, summary here and detail here), which aims to usher in a new age of supervisory challenge to the Irish financial sector, well documented as having had an easy time of it before credit started to get crunchy.

One big challenge for the CBoI will be to get everything up and running before June 2012 (hopefully the recruitment drive wasas good for quality as it seemingly was for quantity!), so all the best to them for that. More pointedly, the acknowledgement that the ramping up of staff numbers will start to be felt in the industry levies asap, coupled with future income streams referenced in their planned aggresive enforcement and fining of non-compliant firms must have any of the stragglers still living in 2006 quaking in their boots.

Very interesting to see the take on Risk Appetite, Risk Tolerance, Risk Assessment Criteria etc applied by a regulator to its industry, rather than my normal vantage point of a risk consultant, either advising on or benchmarking the same facets of individual ERM frameworks within an insurance undertaking. I would have thought the way in which these things are described in Mr. Elderfield's speech should be good guidance for corporate governance code adherence over there (let's face it, it doesn't get better than from the horse's mouth!).

One thing that would make me very uncomfortable as an Insurance consultant is the extent of the crossover between ORSA, QRTs, SFCR and RSR and what is being proposed under PRISM. I would not be keen on, for example, defining 'Risk Profile' for my client in line with Solvency II definitions, only to be contradicted by the regulator's PRISM definition of 'Risk Profile', which is overall solvency needs by any other name.

If I get some spare time, I may run a cross-check between ORSA and PRISM obligations, and work out whether the CBoI is trying to tell the insurance industry how to do an ORSA via subliminal messages - for the life of me, I can't quite work out what this does for the industry that an ORSA run with "appropriate" frequency doesn't.

Solvency II Forum in Dublin - Central Bank of Ireland

All manner of fun no doubt had over on the Emerald Isle today at the CBoI's Solvency II forum. Would love to have been a fly on the wall, however consultants don't get the luxury of days off! Five presentations were seemingly put on the table, and if any of you guys reading in Ireland have anything to add, I'd love to hear it!

First presentation features a nice calendar for 2012, but more importantly the results of a "preparedness for Solvency II" survey issued in September. The following seemed pertinent;

• Around 15% didn't bother replying to and of those who did, over 10% said they were 'not preparing' at all!
• Only 40% into the "implementation and execution" phase
• Very high number of 'other' responses to questions on sponsorship and rollout responsibility, where the options provided were the obvious suspects (CEO, CFO, CRO, COO) - Appointed Actuary the missing link?
• Three quarters were "quite confident" that they will be ready from end of 2012
• Almost 90% think their boards (including NEDs) have "satisfactory" Solvency II knowledge - seems generous to say the least, however these were responses to the Central Bank, so one would be unlikely to say different!
• Top ranked aim of Solvency II programmes was regulatory compliance - that's the spirit, no flannel about business benefits and policyholder protection, just comply!
• 6% not very confident that the CBoI will be ready to conduct supervisory reviews "effectively and appropriately"
• Over 20% "not very confident" that their governance structures are Solvency II compliant (odd, as the requirements of the corporate governance code mirror or indeed surpass Solvency II requirements, and they ought to be complying with those now!)
• 50% haven't defined their ORSA Process yet!

In addition, some other CBoI preparation detail was laid down, most notably;

• Looking to build processes in order to formally accept internal model applications from 1st June 2013 which instinctively feels very late
• Liaising with the industry on the ORSA Supervisory Reporting requirement (which might lead to some element of prescribing content, bearing in mind the ORSA Consultation paper opens up the possibility of using one's ORSA Report to meet that requirement)
• Details on what the CBoI expectes in the "transition year" of 2013 yet to be finalised

Interestingly, in the Internal Models presentation, they are very explicit that Validation must cover all aspects of the models inputs, processes and outputs, not just the internal model itself - this "narrow vs wide" validation scope is something which I haven't seen the FSA be this specific about.

PwC, Central Bank of Ireland - ORSA Briefing

For anyone who just cant wait for the ORSA public consultation next month, PwC and the Central Bank of Ireland have clubbed together to publish this presentation on ORSA (given last week).

From the CBoI section I would flag;

• Firms already have "some" of the components of ORSA in place - in a country where the Financial Condition Report is alive and kicking, you might expect more confidence than that!
• Most of the rest of CBoI's presentation very plain vanilla - concerning if you are looking for firm guidance.
• Not sure how the Q&A went - if anyone attended, I'd love to know!

From the altogether more monied PwC, I would flag;

• Nice process maps that should visualise the suite of work that will ultimately comprise of an end-to-end ORSA process, including the reporting which spews out of the back end.
• A decent attempt at prescribing an ORSA Report structure (of course, if you have seen one punt from the consultancy firms at an "ORSA Report", you have seen them all, buit this does elaborate on each section).

Useful for anything you can extract from it, most concerning perhaps is the divergence in certainty and standard of presentation between the big 4 consultant and the regulator.

Irish Corporate Governance Code for captives

The Central Bank of Ireland pushed out the Corporate Governance Code for Captives this week, which is to all intents and purposes a lightly abridged version of the main event.

My particular interest was their approach to governance and risk appetite, and there is no let-up from the obligations on insurance undertakings in this regard.

• Full qualitative and quantitative documented Risk Appetite required - argued against by some in the industry on the basis of "natuire, scale and complexity"
• Material deviation from Risk Appetite to be reported CBoI within 5 days - regardless of whether parent company or captive manager identifies it
• "Where appropriate", the board may consider a risk committee
• Internal Audit function required, but may use Group resource, or indeed outsource

Handy FAQ document accompanied its release - unlike in the consultation for the main code (in which almost every suggestion was ignored save for tiering supervision between 'big' and 'little'), they have actually made a few tweaks in response to the industry, which is very healthy. They have increased the transitional period by an extra 3 months, dropped the requirement for a deputy chairman, and permitted non-directors to aid in the development of captive strategy.

I am by no means an expert in the area, but they seem like proportional, tailored solutions to retaining a presence in this market, and the Central Bank ought to be applauded for the effort, even if judging by the number of "no's" in the consultation, the industry wanted more!

Elderfield speech to the MacGill Summer School - governance angle

Matthew Elderfield's speech this week to the MacGill Summer School was on the future of Irish banking, but has a heavy corporate governance flavour, so I picked out the pieces with cross-over relevance for Insurance;

• "We have learned from the banking crisis the importance of good corporate governance" - I actually thought we learned about the folie a deux of rancid corporate governance mixed with an intimidated and unskilled regulator, and the inquest seemed to support that. 
• New powers on fitness and probity (for all financial services) will come in later this year (prohibitions, suspensions and removals of execs and non-execs)
• Law containing new powers has been drafted in a way that "grandfathers in" existing board members - regulator however will retrospectively review all bailed-out bank board members if they haven't been replaced since the crisis
• Anticipating legal challenges from said executives!
• Invites said executives to "take up the Minister's (Michael Noonan's) request to act in the public interest" and jump before being pushed
• PRISM framework for a tiered supervisory approach will be rolled out towards the end of this year, and more fully next year - He is "sure it will take a while to bed down" - I'm not sure how much leeway that gives any non-conformists however!

Irish Corporate Governance - first forced shift of director?

Bit busy on the UK front at the moment, so not sure if this is the first "forced" change in directorship as a result of the revised Irish Corporate Governance code, but it is very high profile, being a subsidiary of supermarket behemoth Tesco. The latest deadline of obligations to comply with would have been last week (end of June).

Strange in a number of ways - firstly that as an "adviser", he is reportedly keeping the same influence he wielded as non-executive chairman (surely not in the detail or indeed spirit of the code), and more significantly, that a large, well connected company couldn't find it's way around the code (not reported, but I suspect this would be due to the number of other directorships this gentleman holds) - this surely shows that the Central Bank will be taking no prisoners on the board composition front. Well done!

Central Bank of Ireland - Solvency II FAQs

The Central bank pushed these FAQs out last week (fair play to the various tweeters on the Emerald Isle, who are all much faster than the Central Bank's RSS feed!).

Just like my barnet, it is a bit sparse, but they do note that it will be updated monthly, and you will need to refer back for an updated version (hence I have directed to the landing page, rather than the doc).

Admirable start, and look forward to seeing more of the party line in black and white.